Stability Of Nanoparticles Research Articles

Paclitaxel prodrug nanoparticles boost antitumor efficacy via hitchhiking of human serum albumin

Improving drug delivery efficacy is the key point for enhancing the therapeutic index of medicines. Herein, we report fatty chain conjugated paclitaxel (PTX) prodrugs with a disulfide bond as linker. The formed prodrugs can self-assemble into stable nanoparticles in aqueous solutions, and rapidly transform into long-circulating nanocomplexes via the non-covalent binding to serum albumin in blood, enabling efficient drug delivery and robust antitumor effect. PTX prodrug (PC) with single-chain possess the improved self-assembly and interaction with albumins. The formed PC@albumin nanocomplexes reinforce the responsiveness of prodrug activation, and exhibit the enhanced tumor suppression ability. This strategy of hitchhiking albumin to deliver therapeutic agents holds great promise for enhanced chemotherapy.

Chemical Synthesis and Characterization of Fatty Acid-Capped ZnO Nanoparticles

In the current study, ZnO nanoparticles were obtained using a chemical process employing zinc acetate as the precursor, followed by thermal processing in air. To prevent agglomeration and increase the stability of ZnO nanoparticles, two unsaturated acids (e.g., elaidic acid and linoleic acid) and two saturated acids (e.g., stearic acid and lauric acid) were selected as capping agents. ZnO nanoparticles were investigated before and after surface modification with different fatty acids. Structural and morphological analyses of the samples were performed using FTIR and RAMAN spectroscopy, X-ray diffraction, SEM microscopy, and wetting capacity. Characterization studies revealed that the synthesized ZnO nanoparticles present well-defined crystalline structures, with crystallite sizes varying between 26 and 28 nm, and the average particle size was in the range of 10–55 nm (depending on the type of fatty acids used). The goniometric analysis followed the wetting capacity of the sample surface. The study results reveal that the capping agents have a considerable impact on the surface modification of the nanoparticles by increasing the contact angle. By producing nanoparticles with hydrophobic behavior, there is the possibility of opening up future research for their use in various applications across many industrial fields.

Preparation and stability of lipid nanoparticles excluding 1,2-distearoyl-sn-glycero-3-phosphocholine

Abstract Since 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), the component to keep structure of mRNA-lipid nanoparticle (LNP), is known to cause adverse effects, the replacement of DSPC with the combination of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) and 1-stearoyl-2-hydroxy-sn-glycero-3-phospho ethanolamine (SHPE) was investigated. Specifically, when DSPC of mRNA-LNP was replaced by an 11:1 ratio of DSPE:SHPE, it was found that the size and permeability of mRNA-LNP were the same as those of mRNA-LNP containing DSPC in terms of stability. This result appears to be due to lipid geometry – the ratio of lipid volume to head group area and lipid length.

Controlled release and biological properties of prochitosomes loaded with Arthrospira derived peptides: Membrane stability, chemical, morphological and structural monitoring

In this study, the effects of chitosan-coating on maintaining the integrity and stability of the membrane, structural, and morphological changes, and the release of loaded peptides inside nanoliposomes during various in vitro release, thermal, freeze-thaw, shear, and dehydration (spray-drying) tensions were evaluated. Among different peptidic fractions (100, 30, and 10 kDa), the Arthrospira derived PF-30 kDa showed a higher nutritional and biological value. PF-30kDa was loaded successfully (EE ~ 90 %) inside nanoliposomes (NLs) and its stabilization was done with chitosan coating (0.1–0.8 %). Nanochitosomes (NCs-0.4 %) had more structural stability (size, EE, and biological activity) at different temperatures, freeze-thaw tension, and digestive system. The placement of peptides in the vesicle structure was confirmed by FTIR analysis. Also, the changes in the morphological states, agglomeration, or destruction of the liposome membrane (SEM, AFM, and TEM) were evaluated before and after the tensions. Membrane coating led to the transformation of freeze-dried liposomes (FD-NLs) from thin, porous, and fragile layers to thick plates, rough and resistant structures (FD-NCs). These characteristics led to maintaining physical stability, homogeneity, zeta potential, and EE of nanoparticles (freeze and spray-dried) after reconstitution. The results of this study will effectively contribute to the production of solidified delivery systems with long-term durability, bioavailability, and biological activity of loaded nutrients and drugs.

Unveiling the Potential of CuO and Cu2O Nanoparticles against Novel Copper-Resistant Pseudomonas Strains: An In-Depth Comparison.

Four novel Pseudomonas strains with record resistance to copper (Cu2+) previously isolated from ecologically diverse samples (P. lactis UKR1, P. panacis UKR2, P. veronii UKR3, and P. veronii UKR4) were tested against sonochemically synthesised copper-oxide (I) (Cu2O) and copper-oxide (II) (CuO) nanoparticles (NPs). Nanomaterials characterisation by X-ray diffractometry (XRD), X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy (FTIR), and High-Resolution Transmission Electron Microscopy (HRTEM) confirmed the synthesis of CuO and Cu2O NPs. CuO NPs exhibited better performance in inhibiting bacterial growth due to their heightened capacity to induce oxidative stress. The greater stability and geometrical shape of CuO NPs were disclosed as important features associated with bacterial cell toxicity. SEM and TEM images confirmed that both NPs caused membrane disruption, altered cell morphology, and pronounced membrane vesiculation, a distinctive feature of bacteria dealing with stressor factors. Finally, Cu2O and CuO NPs effectively decreased the biofilm-forming ability of the Cu2+-resistant UKR strains as well as degraded pre-established biofilm, matching NPs' antimicrobial performance. Despite the similarities in the mechanisms of action revealed by both NPs, distinctive behaviours were also detected for the different species of wild-type Pseudomonas analysed. In summary, these findings underscore the efficacy of nanotechnology-driven strategies for combating metal tolerance in bacteria.

Selenium nanoparticles stabilized with chitosan for fortifying dairy products

Relevance. One solution to the problem of selenium deficiency is the enrichment of socially important food products, in particular dairy products, with bioavailable forms of selenium. Such forms include selenium nanoparticles. The aim of the work is to develop a dairy product enriched with selenium nanoparticles stabilized with chitosan.Methods. According to dynamic light scattering spectroscopy, a sample of selenium nanoparticles stabilized with chitosan has a monomodal size distribution with an average hydrodynamic particle radius of 25 nm.Results. Quantum chemical modeling of selenium nanoparticles stabilized by chitosan has revealed that the most energetically favorable interaction is the interaction of the surface of selenium nanoparticles with the hydroxo group attached to the C3 glucosamine residue of chitosan. A study was conducted of the influence of technological parameters on the stability of selenium nanoparticles stabilized with chitosan. It was found that increasing the exposure time leads to an increase in the average hydrodynamic radius of selenium nanoparticles stabilized by chitosan. In the case of pH, an inverse relationship is observed: particles with the largest average hydrodynamic radius are found in samples with an acidic environment (pH ˂ 5). As part of a study of the influence of technological parameters on the stability of selenium nanoparticles stabilized by chitosan, it was found that selenium nanoparticles stabilized by chitosan can be used as a source of selenium for food products that have a neutral pH, but can be subjected to heat treatment at temperatures above 70 °C in for 5–15 minutes, in particular pasteurized milk. A study of pasteurized milk fortified with selenium nanoparticles stabilized by chitosan showed that there were no significant changes in titratable acidity, surface tension and pH of milk, as well as the average hydrodynamic radius of casein micelles after milk fortification. The value of antioxidant activity increases by 0.88% — from 6.50 to 7.38%.

Impact of calcium-reinforcement on stability, bioavailability, and bioactivity of quercetin-loaded zein/alginate-pectin nanoparticles.

Cationic calcium ions can crosslink anionic alginate and pectin molecules. It was hypothesized that calcium crosslinking would improve the stability and functionality of biopolymer nanoparticles consisting of zein cores coated by alginate-pectin shells. The effects of calcium ion addition on the structural, physicochemical, and gastrointestinal properties of quercetin-loaded zein/alginate-pectin nanoparticles were therefore investigated. The nanoparticles remained stable to aggregation at calcium ion concentrations of 9 mmol/L or less but aggregated and sedimented at higher concentrations. Calcium ion reinforcement increased the particle dispersion stability even at NaCl concentrations up to 1.4 molL-1. The presence of the calcium ions also reduced quercetin release during the early stages of simulated gastrointestinal digestion but increased its release during the later stages. The relatively high release (56.1%) of quercetin from the calcium-reinforced nanoparticles after digestion resulted in higher intracellular antioxidant activities. The pharmacokinetics of the encapsulated quercetin was measured after its oral administration to rats. The maximal concentration (Cmax) of quercetin in rat plasma for calcium-reinforced nanoparticles was 6.1% higher than non-reinforced nanoparticles; the half-life (t1/2) increased by 17.5%, and the mean retention time (MRT) was 10.0% higher (P < 0.05). These results suggest that calcium ion addition improved the performance and bioavailability of nutraceutical-loaded biopolymer nanoparticles. This might find application in the food and beverage industry. © 2024 Society of Chemical Industry.

Green engineering of NiO nanoparticles decorated with Arachis hypogaea shell extract for biomedical applications

Abstract We attempted to synthesize nickel oxide nanoparticles (NiO-NPs) utilizing waste Arachis hypogaea (peanut) shell extract and studied their structural, morphological, and biological performance for biomedical applications. The green engineered NiO-NPs possessed a face-centered cubic structure with an average particle size of 20 nm in highly crystalline form. NiO-NPs were shown to have an optical resonance peak at 327 nm with 3 eV as the optical band gap according to the UV–visible spectra, and the stretching band between Ni–O were evidenced from the FTIR and Raman spectrum. Utilizing green approach the stable nanoparticles were obtained with average particle size of 31 nm from SEM analysis; zeta potential value of −17.6 mV, and PDI as 0.68, revealed the formation of spherical nanoparticles with distinct morphologies without aggregation. XPS analysis confirmed the oxidation states of the elements Ni (2p) and O (1s). This approach may help to increase the surface area, increasing the possibility of nanoparticles interacting with bacterial cells. Furthermore, the presence of nickel and the oxygen oxidation state were confirmed by XPS. Proteus vulgaris, Streptococcus oralis, Bacillus subtilis, and Escherichia coli were found to be susceptible to the antibacterial action of the produced NiO-NPs, with a maximal zone of inhibition of 10.25 mm at 500 μg/ml for P. vulgaris. For P. vulgaris and E. coli, the minimum inhibitory concentrations of NiO were 5.36 and 12.55 %, respectively, at 31.25 μg mL−1. We hereby claim that green engineered NiO NPs decorated with A. hypogaea shell extract have great potential for pharmaceutical and biomedical applications.

Preparation of Disulfide/Trisulfide Core-Cross-Linked Polycarbonate Nanocarriers for Intracellular Reduction-Triggered Drug Release.

Polymeric nanocarriers have attracted significant attention in the field of anticancer drug delivery due to their unique advantages. However, designing nanocarriers that can maintain stability in the bloodstream while achieving specific drug release within tumor cells remains a major challenge. To address this issue, constructing reversible cross-linked polymeric nanocarriers that are sensitive to the intracellular reducible glutathione (GSH) characteristic of the tumor microenvironment is a promising strategy. Based on this, we designed and synthesized two novel six-membered bicyclic carbonate monomers containing disulfide (DSBC) and trisulfide (TSBC) bonds. Through a one-step ring-opening polymerization, a series of reduction-sensitive polycarbonate copolymers (i.e., PEG-PDSBC and PEG-PTSBC) were prepared, and doxorubicin (DOX)-loaded nanoparticles were fabricated using a nanoprecipitation method. The in vitro drug release behaviors of these nanoparticles were systematically investigated. The results showed that these polymers, due to the cross-linked structure formed by the ring-opening polymerization of their bicyclic monomers, could self-assemble into stable nanoparticles. Under different concentrations of glutathione, DOX-loaded PEG-PTSBC nanoparticles demonstrated faster drug release, indicating more optimized intracellular drug release properties. Further cytotoxicity experiments revealed that both types of blank nanoparticles exhibited good biocompatibility with the 4T1 and NIH-3T3 cells. Fluorescence microscopy and flow cytometry results further indicated that DOX-loaded PEG-PTSBC nanoparticles released more drugs in 4T1 cells, significantly inhibiting tumor cell growth compared with DOX-loaded PEG-PDSBC nanoparticles, with no noticeable difference in NIH-3T3 normal cells. In conclusion, this study suggests that trisulfide cross-linked polycarbonate-based nanocarriers hold promise as an anticancer drug delivery system that combines stability in the bloodstream with specific intracellular drug release, offering new insights for the development of novel, efficient, and safe anticancer nanomedicines.

Stabilization and Surface Functionalization of Palladium Disulfide Nanoparticles with Acetylene Derivatives.

Metal chalcogenide nanoparticles have been attracting extensive attention in diverse fields. Traditionally these nanoparticles are stabilized by organic ligands such as thiols and amines involving nonconjugated core-ligand interfacial interactions. In the present study, a facile wet-chemistry method is described for the synthesis of palladium disulfide (PdS2) nanoparticles capped with acetylene derivatives. Spectroscopic and electrochemical measurements suggest that conjugated Pd-C≡ linkages are formed at the core-ligand interface and facilitate electronic coupling and hence manipulation of the nanoparticle optical and electronic properties. The unique interfacial linkages also allow further functionalization of the nanoparticles by metathesis reaction with olefin derivatives, as manifested in the reaction with vinylferrocene. This research opens new avenues for the structural engineering and functionalization of metal chalcogenide nanoparticles.

T7 Peptide-modified macrophage membrane-coated nanoplatform for enhanced glioma treatment

The efficient and secure delivery of intravenous chemotherapeutic agents across the blood–brain barrier (BBB) to the precise location of a brain tumor is a crucial element in glioma treatment. Herein, we introduce a biomimetic nanoplatform (T7-M-C/S) comprising a core made up of irinotecan hydrochloride (CPT11) and its bioactive metabolite, 7-Ethyl-10-hydroxycamptothecin (SN38), surrounded by a layer of T7-peptide-modified macrophage membrane. CPT11 spontaneously assembles with SN38 into stable and water-dispersible nanoparticles (C/S), greatly enhancing the water solubility of SN38. The integration of the modified peptide with the inherent proteins expressed by macrophage cells confers the nanoplatform with enhanced bioavailability and robust glioma-targeting abilities, ultimately resulting in superior therapeutic outcomes. These discoveries highlight a drug delivery system characterized by a high drug loading capacity, leveraging the macrophage membrane, and promising significant potential for glioma treatment.

Core-Shell Confined Stable Polymer Nanoparticles with Tunable Clusteroluminescence.

Clusteroluminescent polymers have the most potential to be used in light conversion agricultural films due to tunable emission wavelength and large-scale production, but they are still limited by shortcomings such as poor stability and sensitivity to melting processes. In this work, we propose a core-shell confined stable clusteroluminescent polymeric nanoparticle strategy with adjustable shell thickness. By the employment of a combination of solvent and heat treatment methods, the structures, rigid-flexible properties, and aggregation states of the core polymer chains have been modified. The presence of cross-linked shells has significantly enhanced the stability of the clusteroluminescent nanoparticles, ensuring that they retain their structure form even after undergoing high temperature and shear. Finally, the stable agricultural light conversion films with tunable clusteroluminescence are obtained via melt blending of the core-shell confined nanoparticles and polyethylene (PE). Due to the shell confinement effect, when melt-blended, the shell can protect the clusteroluminescent polymer within the core from the effects of high temperature and shear. It is anticipated that the completion of this work will provide a significant foundation for the large-scale application of cluster-luminescent polymers in agriculture.

Synthesis of metallic nanoparticles using biometabolites: mechanisms and applications.

Bio-metabolites have played a crucial role in the recent green synthesis of nanoparticles, resulting in more versatile, safer, and effective nanoparticles. Various primary and secondary metabolites, such as proteins, carbohydrates, lipids, nucleic acids, enzymes, vitamins, organic acids, alkaloids, flavonoids, and terpenes, have demonstrated strong metal reduction and stabilization properties that can be utilized to synthesize nanomaterials and influence their characters. While physical and chemical methods were previously used to synthesize these nanomaterials, their drawbacks, including high energy consumption, elevated cost, lower yield, and the use of toxic chemicals, have led to a shift towards eco-friendly, rapid, and efficient alternatives. Biomolecules act as reducing agents through deprotonation, nucleophilic reactions, transesterification reactions, ligand binding, and chelation mechanisms, which help sequester metal ions into stable metal nanoparticles (NPs). Engineered NPs have potential applications in various fields due to their optical, electronic, and magnetic properties, offering improved performance compared to bulkier counterparts. NPs can be used in medicine, food and agriculture, chemical catalysts, energy harvesting, electronics, etc. This review provides an overview of the role of primary and secondary metabolites in creating effective nanostructures and their potential applications.

Stable Polymer-Lipid Hybrid Nanoparticles Based on mcl-Polyhydroxyalkanoate and Cationic Liposomes for mRNA Delivery.

Background/Objectives: The development of polymer-lipid hybrid nanoparticles (PLNs) is a promising area of research, as it can help increase the stability of cationic lipid carriers. Hybrid PLNs are core-shell nanoparticle structures that combine the advantages of both polymer nanoparticles and liposomes, especially in terms of their physical stability and biocompatibility. Natural polymers such as polyhydroxyalkanoate (PHA) can be used as a matrix for the PLNs' preparation. Methods: In this study, we first obtained stable cationic hybrid PLNs using a cationic liposome (CL) composed of a polycationic lipid 2X3 (1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16,20-tetraazahexacosane tetrahydrochloride), helper lipid DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), and the hydrophobic polymer mcl-PHA, which was produced by the soil bacterium Pseudomonas helmantisensis P1. Results: The new polymer-lipid carriers effectively encapsulated and delivered model mRNA-eGFP (enhanced green fluorescent protein mRNA) to BHK-21 cells. We then evaluated the role of mcl-PHA in increasing the stability of cationic PLNs in ionic solutions using dynamic light scattering data, electrophoretic mobility, and transmission electron microscopy techniques. Conclusions: The results showed that increasing the concentration of PBS (phosphate buffered saline) led to a decrease in the stability of the CLs. At high concentrations of PBS, the CLs aggregate. In contrast, the presence of isotonic PBS did not result in the aggregation of PLNs, and the particles remained stable for 120 h when stored at +4 °C. The obtained results show that PLNs hold promise for further in vivo studies on nucleic acid delivery.

Emerging Roles of Gossypol in Therapy: Innovations in Prodrug Design and Nanoformulation Frontiers.

Stimuli activatable systems have the potential to deliver drugs to targeted areas by releasing therapeutic agents in response to diseased specific microenvironments such as the acidic environment commonly found in diseased tissues. This review article focuses on gossypol, a bioactive compound with inherent toxicity attributed to various factors, including the presence of its formyl groups. It highlights the potential of imine-linked gossypol-based prodrugs and nanoparticle formulations for targeted delivery and controlled release. The unique presence of polyphenolic cores on gossypol can be utilized to prepare nanoparticles. This review offers valuable insights into designing safer and more effective drug delivery systems by elucidating the masking effect and stimuli-responsive release mechanisms. Numerous examples demonstrate the conversion of formyl groups to imines, creating prodrugs that mask reactive functionalities and offer pH-responsive release. This insight can guide the design of combination therapeutics, where a second drug with an amine terminal group can form imine-linked prodrugs. Additionally, the second part discusses the use of polyphenolic moieties to create stable nanoparticles from infinite polymeric networks. Through a comprehensive examination of gossypol's properties and applications, this review emphasizes the broader implications of such a masking strategy for optimizing the therapeutic benefits of many similar bioactive compounds while minimizing adverse effects.

Dual-functionalized architecture enables stable and tumor cell-specific SiO2NPs in complex biological fluids.

Most commercial anticancer nanomedicines are administered intravenously. This route is fast and precise as the drug enters directly into the systemic circulation, without undergoing absorption processes. When nanoparticles come into direct contact with the blood, however, they interact with physiological components that can induce colloidal destabilization and/or changes in their original biochemical identity, compromising their ability to selectively accumulate at target sites. In this way, these systems usually lack active targeting, offering limited therapeutic effectiveness. In the literature, there is a paucity of in-depth studies in complex environments to evaluate nanoparticle stability, protein corona formation, hemolytic activity, and targeting capabilities. To address this issue, fluorescent silica nanoparticles (SiO2NPs) are here functionalized with zwitterionic (kinetic stabilizer) and folate groups (targeting agent) to provide selective interaction with tumor cell lines in biological media. The stability of these dually functionalized SiO2NPs is preserved in unprocessed human plasma while yielding a decrease in the number of adsorbed proteins. Experiments in murine blood further proved that these nanoparticles are not hemolytic. Remarkably, the functionalized SiO2NPs are more internalized by tumor cells than their healthy counterparts. Investigations of this nature play a crucial role in garnering results with greater reliability, allowing the development of nanoparticle-based pharmaceutical drugs that exhibit heightened efficacy and reduced toxicity for medical purposes.

Transformation of Engineered Copper Oxide Nanoparticles in Surface Waters.

Copper oxide nanoparticles (CuO-NPs) are widely used for their catalytic properties, conductive capacity, and innovations in the fields of superconductors, alloys, and solar energy sensors. To better understand the impact of water chemistry on the stability of CuO nanoparticles, a series of measurements were carried out on nanoparticles suspended in pure water, natural water, and water enriched with natural organic matter fulvic acid (FA). ICP-MS characterization in single-particle mode (SP-ICP-MS) was performed to determine the stability or transformation of nanoparticles in contrasting water conditions. We first observed that particle sedimentation was very fast in pure Milli-Q water. The addition of FA favored the dissolution of CuO-NPs with an increase in the dissolved copper concentration, for both Milli-Q water and natural water. The presence of FA also reduced the size of CuO-NPs (i.e., less aggregation) measured in natural water. By comparing signals of single particles, FA decreased nanoparticle numbers as well, confirming the increase in dissolution of CuO-NPs over time. The transformation products of CuO-NPs are important in the ecological context since the uptake and toxicity of parent nanoparticles differ from those of the chemical species in solution. Further considerations are needed on the fate of released NPs to better assess their exposure pathways to aquatic organisms and potential environmental risks.

Green synthesis of copper oxide nanoparticles using solanum melongena seeds extract and its applications in degradation of Rose Bengal dye, antibacterial, catalytic reduction and antioxidant activity

The generation of copper oxide (CuO) nanoparticles using a biogenic extract (solanum melongena seeds) was the primary focus of this study. As prepared catalyst has been utilized for dye degradation of Rose Bengal and studies on Antibacterial and Antioxidants. The catalyst was characterized for its structural aspects by using Scanning electron microscopy - energy dispersive spectroscopy (SEM-EDS), Powder X-ray Diffraction (PXRD), Fourier Transform - InfraRed spectroscopy (FT-IR), Thermogravimetric Analysis (TGA), Brunauer-Emmett-Teller (BET) and UV–Visible DRS. The characterization results of XRD shows that the catalyst is in monoclinic phase. Copper Oxide is irregular in morphology and the average particle size is 47.97 nm which can be obtained using the SEM images and EDS spectra shows the Oxygen and Copper atoms presence which indicates the free from impurities of the fabricated biogenic CuO nanoparticles. FT-IR result indicated the stretching frequency of Cu–O appears at 487 cm−1. TGA data reveal that high-purity and thermally stable nanoparticles were fabricated, by the absence of significant weight losses at temperatures greater than 400 °C. Through UV–Visible DRS the calculate band gap was found to be 2.8eV. Based on the characterisation results the best catalyst was used to degrade the Rose Bengal dye within 60 min and also carried out the antibacterial and antioxidant activity which was found to be satisfactory when compared with their standard values.

Cetuximab functionalized chitosan/hyaluronic acid-based nanoparticles loaded with cabazitaxel enhances anti-tumor efficacy in DMBA-induced breast cancer model in rats through spatial targeting

The article discusses the ionic gelation of cationic chitosan (CS) with anionic hyaluronic acid (HA) sodium salt to form nanoparticles in the range of 125 nm. The particles were further functionalized with cetuximab to endow it with the ability to spatially target the tumor over-expressing EGFR. Solid-state characterization of the particles using XRD, FTIR, and DSC revealed the formation of stable nanoparticles with Cabazitaxel loaded in the amorphous nanostructure. XPS study used to assess the surface characteristics indicated that the cetuximab was successfully anchored on the surface of the particle. The prepared CS-HA-Cmab-NP elicited a pH-responsive drug release behavior due to the presence of CS in the matrix. In vitro performance of the nanoparticles was evaluated on MDA-MB-231 breast cancer cell lines showed overall increase in efficacy. In vivo pharmacokinetic and anti-tumor effect evaluated in female Sprague Dawley rats indicated that the Cmab-conjugated nanoparticles improved half-life of cabazitaxel and tumor reduction capability with higher survival rate and lower reduction in body weight. The results indicate that CS/HA nanoparticles anchored with cetuximab show enhanced efficacy in reducing the breast cancer tumor in DMBA-induced breast tumor model through spatial targeting, consequently reducing the systemic toxicity.

Advancements in Nanotechnology-Based Paclitaxel Delivery Systems: Systematic Review on Overcoming Solubility, Toxicity, and Drug Resistance Challenges in Cancer Therapy

Background: Paclitaxel (PTX) is a potent chemotherapeutic widely used to treat cancers, including breast and ovarian cancer. However, its poor water solubility, severe side effects, and susceptibility to multidrug resistance (MDR) limit its clinical effectiveness. Recent research focuses on nanotechnology-based delivery systems, such as nanoparticles, liposomes, and dendrimers, to enhance PTX solubility, bioavailability, and targeted delivery. This systematic review analyzed studies from 2019 to 2023 that explore advancements in PTX delivery, focusing on improving therapeutic outcomes and reducing toxicity. Methods: A systematic search was conducted using PubMed, Scopus, Google Scholar, and Web of Science. Forty-five primary research studies meeting inclusion criteria for nanotechnology-based systems, targeted delivery, and MDR strategies were analyzed for improvements in PTX delivery efficacy. Results: The review identified significant advancements in PTX delivery through nanoparticle and targeted systems. Polymer-based nanoparticles, ligand-conjugated carriers, and co-delivery systems with MDR inhibitors showed improved PTX solubility, stability, and selective targeting. Theragnostic platforms combining diagnostics and therapy offered real-time tracking, enhancing personalized treatment. Conclusion: While nanotechnology-based PTX delivery shows promise in overcoming PTX's limitations, challenges remain, particularly in nanoparticle stability, tumor microenvironment barriers, and regulatory hurdles. Future research should address these challenges to enable the clinical translation of PTX systems, providing more effective, accessible cancer treatments worldwide.